0.87 USD
↗ 0.05 (6.23%)LIVE (AS OF 03:18 PM EDT)
Actuate Therapeutics, Inc. Common stock
ACTUNASDAQ • USD
Market: OPEN
ACTU is currently priced at $0.87. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 2, 2026.
Open?$0.85
High?$0.93
Low?$0.78
Prev. Close?$0.82
Volume?160.1K
Avg. Volume?396.7K
VWAP?$0.87
Rel. Volume?0.40x
Bid / Ask
Bid?$0.75 × 100
Ask?$0.99 × 100
Spread?$0.24
Midpoint?$0.87
Valuation & Ratios
Market Cap?19.7M
Shares Out?24.0M
Float?9.5M
Float %?40.3%
P/E Ratio?N/A
P/B Ratio?19.91
EPS?-$0.85
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
Employees
12
Market Cap
19.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-08-13
Address
1751 RIVER RUN
FORT WORTH, TX 76107
Phone: 847-986-4190
FORT WORTH, TX 76107
Phone: 847-986-4190
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?45
Piotroski F-Score?0/9Weak
Altman Z-Score?-54.62Distress
Confidence?42%Low
Short InterestHigh
Short % of Float?11.50%High
Short Interest?1.1M
Days to Cover?3.2
Free Float9.5M
Avg Daily Volume341.5K
Settlement Date2026-09-15
Financial Health
Current Ratio?1.25Adequate
Quick Ratio?1.25Adequate
Cash Ratio?1.16Strong
Debt/Equity?0.04Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?19.91HIGH▾
Peers100
S&P7
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-2,067.8%WEAK▾
S&P3
ROA?-393.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-19836202
Enterprise Value?$15.3M
Fundamentals ratios updated end of day